2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-12159A
    MK-0668 mesylate 865111-04-2 98%
    MK-0668 mesylate is an amino acid-based, potent antagonist of unactivated VLA-4, with an IC50) of 0.13 nM in human whole blood. And MK-0668 mesylate exhibits IC50s of 0.19 nM in dogs, 0.21 nM in rhesus monkeys, and 0.4 nM in rats.
    MK-0668 mesylate
  • HY-121619
    Jacaric acid 28872-28-8 98%
    Jacaric acid is a conjugated linolenic acid, which inhibits viability in cells PC-3 (IC50 is 11.8 μM), LNCaP (IC50 is 2.2 μM) and DLD-1, induces apoptosis and necrosis. Jacaric acid exhibits anticaner activity against prostate cancer and adenocarcinoma. Jacaric acid exhibits immunomodulating activity in murine peritoneal macrophages as an immunopotentiator. Jacaric acid is orally active.
    Jacaric acid
  • HY-121889
    FQ 190838-76-7 98%
    FQ is a tyrosinase inhibitor that effectively inhibits the diphenolase activity of mushroom tyrosinase (IC50=120 μM). FQ can be used in the study of pigmentation.
    FQ
  • HY-121977
    IKs124 199335-15-4 98%
    IKs124 is KCNE2/KCNQ1 potassium channel blocker with the with an IC50 of 8 nM. IKs124 can be used for study of peptic ulcers.
    IKs124
  • HY-122063
    FR260330 442198-67-6 98%
    FR260330 is a selective, orally active inhibitor for inducible nitric oxide synthase (iNOS) through suppression of iNOS dimerization. FR260330 inhibits the NO accumulation in rat splenocytes and human DLD-110 cells, with IC50 of 27 and 10 nM. FR260330 ameliorates the Lipopolysaccharides (HY-D1056)-induced inflammatory diseases in rats model.
    FR260330
  • HY-122158
    CRAC channel inhibitor-1 903591-53-7 98%
    CRAC channel inhibitor-1 (compound 55) is a CRAC channel inhibitor. CRAC channel inhibitor-1 can be used in immunology-related research.
    CRAC channel inhibitor-1
  • HY-122175
    ZK-158252 162362-36-9 98%
    ZK-158252 is a leukotriene B4 type-2 receptor (BLT2) antagonist.
    ZK-158252
  • HY-122270
    Kahweol stearate 108214-31-9 98%
    Kahweol stearate is a diterpenoid ester found in coffee that exhibits anti-inflammatory, anticancer, and antiangiogenic activities.
    Kahweol stearate
  • HY-122536
    Ricinelaidic acid 540-12-5 98%
    Ricinelaidic acid, a 12-hydroxy fatty acid，is a leukotriene B4 (LTB4) receptor antagonist with the Ki of 2 μM in porcine neutrophil membranes. Ricinelaidic acid inhibits chemotaxis and calcium flux induced by LTB4 in isolated human neutrophils (IC50=10 and 7 μM, respectively). Ricinelaidic acid inhibits bronchoconstriction induced by LTB4 in rats.
    Ricinelaidic acid
  • HY-122848
    DDR1/2 inhibitor-3 2241813-33-0 98%
    DDR1/2 inhibitor-3 (5n) is a DDR1/2 inhibitor, with IC50 values​of 9.4 and 20.4 nM, respectively. DDR1/2 inhibitor-3 can be used in anti-inflammatory research.
    DDR1/2 inhibitor-3
  • HY-12288R
    Ozanimod (Standard) 1306760-87-1 98%
    Ozanimod (Standard) is the analytical standard of Ozanimod. This product is intended for research and analytical applications. Ozanimod (RPC-1063), a sphingosine 1-phosphate (S1P) receptor modulator that binds with high affinity selectively to S1P receptor subtypes 1 (S1P1) and 5 (S1P5). Ozanimod has modulate effect for hS1P1 and hS1P5 receptor with EC50s of 1.03 nM and 8.6 nM, respectively. Ozanimod can be used for the research of relapsing multiple sclerosis (MS).
    Ozanimod (Standard)
  • HY-12290R
    Arg-Gly-Asp-Ser (Standard) 91037-65-9 98%
    Arg-Gly-Asp-Ser (Standard) is the analytical standard of Arg-Gly-Asp-Ser. This product is intended for research and analytical applications. Arg-Gly-Asp-Ser is an integrin binding sequence that inhibits integrin receptor function. Arg-Gly-Asp-Ser directly and specifically bind pro-caspase-8, pro-caspase-9 and pro-caspase-3, while it does not bind pro-caspase-1.
    Arg-Gly-Asp-Ser (Standard)
  • HY-122989
    Aristolactam BIII 53948-10-0 98%
    Aristolactam BIII is a potent DYRK1A inhibitor and inhibits the kinase activity of DYRK1A in vitro (IC50= 9.67 nM. Aristolactam BIII rescues the proliferative defects of DYRK1A transgenic (TG) mouse-derived fibroblasts and neurological and phenotypic defects of DS-like Drosophila models.
    Aristolactam BIII
  • HY-123038
    CVT-5440 531506-64-6 98%
    CVT-5440 is a xanthine based, selective, high affinity A2B adenosine receptors (AdoR) antagonist with a Ki of 50 nM (selectivity A1> 200; A2A>200; A3>167). CVT-5440 has the potential for asthma research.
    CVT-5440
  • HY-123219
    Salifluor 78417-90-0 98%
    Salifluor is a broad spectrum antimicrobial agent that has been investigated for its abilities to inhibit dental plaque formation. Salifluor can act as an effective anti-inflammatory agent.
    Salifluor
  • HY-123270
    RP23618 207991-30-8 98%
    RP23618 is a non peptidic RANTES antagonist with the IC50 of 3 μM. RP23618 inhibit RANTES-induced chemotaxis of THP-1 cells.
    RP23618
  • HY-123277
    IMB-10 307525-40-2 98%
    IMB-10 is an αMβ2 integrin ligand. IMB-10 inhibits αMβ2-dependent migration and inflammation-induced neutrophil emigration.
    IMB-10
  • HY-123289
    CP-690550A 1243290-37-0 98%
    CP-690550A is an analogue of Tofacitinib (HY-40354). CP-690550A is a dual inhibitor of JAK2 and JAK3.
    CP-690550A
  • HY-123388
    SCH 12223 free base 89109-20-6 98%
    SCH 12223 free base is an orally active gastroprotective agent. SCH 12223 free base exhibits gastrointestinal protective action against various noxious stimuli. SCH 12223 free base can be used for research on gastrointestinal diseases.
    SCH 12223 free base
  • HY-123391
    PD 127443 121502-05-4 98%
    PD 127443 is an inhibitor of 5-lipoxygenase and cyclooxygenase. PD 127443 has anti-inflammatory activity.
    PD 127443
Cat. No. Product Name / Synonyms Application Reactivity